Skip to main content
The Bright Side
arrow_backHome
Bowel cancer “melted away” after immunotherapy, then stayed away
Science
ScienceDaily (all)EN
October 10, 2026

Bowel cancer “melted away” after immunotherapy, then stayed away

A short course of immunotherapy before surgery may offer remarkably durable protection for some patients with stage two or three bowel cancer. In the NEOPRISM-CRC trial, 32 patients with a specific genetic form of bowel cancer received pembrolizumab for up to nine weeks before surgery instead of the usual post-surgery chemotherapy. After nearly three years of follow-up, none of the patients had experienced a cancer recurrence, including those who still had small traces of disease after treatment.

Read More

Curated from ScienceDaily (all). Classified as Science by AI, which sometimes makes mistakes.

Why are you reporting this article?

Why are you reporting this article?
0/500

More like this

More ›
Davar10/12/2026

Beaver tail, duck legs: the ancient creature discovered in China

Researchers discovered a fossil of an ancient animal that swam like a duck, walked sideways like an otter and bore a tail similar to that of a beaver | The fossil, about 165 million years old, was preserved with remnants of skin and fur, and revealed new findings about mammal evolution during the dinosaur era

NASA News10/12/2026

NASA’s SpaceX CRS-35 Mission to Launch Health Research

NASA experiments focused on human and plant health and drug-resistant organisms will travel to the International Space Station aboard SpaceX’s 35th Commercial Resupply Services mission for the agency from Cape Canaveral Space Force Station in Florida, advancing research that benefits life on Earth and future exploration. This research supports astronaut health during long-duration missions through […]